Clivus chordomas: a systematic review and meta-analysis of contemporary surgical management.

医学 斜坡 脊索瘤 外科 入射(几何) 人口 颅骨 物理 环境卫生 光学
作者
Moujahed Labidi,Kentaro Watanabe,S. Bouazza,Damien Bresson,Anne Laure Bernat,Bernard George,Sébastien Froelich
出处
期刊:PubMed 卷期号:60 (4): 476-84 被引量:59
链接
标识
摘要

Chordomas are rare bony lesions arising from notochordal remnants. Technical advances in endoscopic surgery have allowed the median endonasal corridor to be used for a larger number of chordoma cases. However, very few studies have critically examined the data in support of the anterior midline approach (AMA), as compared to lateral and posterolateral transcranial corridors.A systematic search of the literature was done in March 2016 using EMBASE and PubMed for articles published between January 2006 and March 2016 to identify surgical series of clivus chordomas. Only articles describing chordomas cases arising from the clivus of craniocervical junction were included in the analysis.Twenty-seven articles were included in this systematic review, amounting to a total of 1050 patients. The weighted mean rate of GTR was 39.9% (range 0-78.3%) in this patient population. The surgical approaches were described in 16 papers, with 6 series reporting on surgeries done exclusively through the midline corridor (116 patients). In the remaining 10 series (495 patients), the AMA was used in a mean of 56.8% of cases. In studies including patients operated solely through an AMA, a higher GTR rate was obtained (60.7% vs. 42.0%). Postoperative complications were also different between the two cohorts, with lower cranial nerves deficits and CNS infections but higher incidence of CSF leak in the AMA group than in mixed surgical series. In a weighted mean follow-up time of 52.1±21.9 months, recurrences were observed in 38.2% of the total population of patients. Among 423 patients, the weighted 5-year PFS was 49.9±12.1% and the 5-year OS was 73.9±11.2% (N.=391). A random effects model was performed, combining data from studies reporting recurrence rates in GTR and non-GTR (N.=610), with a total odds ratio of having a recurrence for patients who had GTR vs non-GTR of 0.289 (95CI 0.184-0.453).In this systematic review and meta-analysis of studies published in the last decade, an estimated 5-year PFS of 49.9% and 5-year OS of 73.9% were obtained. The weighted mean GTR rate in the included study was 39.9%, with a significantly reduced occurrence of recurrence in complete resections. Although anterior midline approaches may allow for higher GTR rates and fewer neurological morbidity than traditional transcranial routes, their impact of long-term survival and disease control remains largely unknown.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
今后应助超开心采纳,获得10
1秒前
邵洋完成签到,获得积分10
1秒前
大气听枫发布了新的文献求助10
1秒前
2秒前
科目三应助louiselong采纳,获得10
2秒前
baobao发布了新的文献求助10
3秒前
负责冰海发布了新的文献求助10
3秒前
英姑应助李JJ采纳,获得10
4秒前
茶茶发布了新的文献求助10
4秒前
4秒前
5秒前
称心问枫发布了新的文献求助10
5秒前
不说完成签到,获得积分10
6秒前
浮游应助lujianqi采纳,获得10
7秒前
Lim1819完成签到 ,获得积分10
7秒前
夕荀发布了新的文献求助10
8秒前
香蕉觅云应助义气尔芙采纳,获得10
9秒前
坚强的安柏完成签到,获得积分10
12秒前
season完成签到,获得积分10
12秒前
懒123发布了新的文献求助10
12秒前
13秒前
香蕉觅云应助顺顺顺采纳,获得10
14秒前
14秒前
今后应助舒心新儿采纳,获得10
15秒前
15秒前
英姑应助御白采纳,获得10
16秒前
CC完成签到,获得积分10
17秒前
桐夜完成签到 ,获得积分10
17秒前
善学以致用应助口袋小镇采纳,获得10
17秒前
18秒前
CC发布了新的文献求助10
21秒前
浪子发布了新的文献求助10
21秒前
louiselong发布了新的文献求助10
21秒前
baobao完成签到,获得积分10
23秒前
24秒前
24秒前
高磊一航完成签到,获得积分10
25秒前
故槿完成签到 ,获得积分10
25秒前
传奇3应助小白采纳,获得10
26秒前
伶俐皮卡丘完成签到,获得积分10
28秒前
高分求助中
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
哈工大泛函分析教案课件、“72小时速成泛函分析:从入门到入土.PDF”等 660
Comparing natural with chemical additive production 500
The Leucovorin Guide for Parents: Understanding Autism’s Folate 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 500
A Manual for the Identification of Plant Seeds and Fruits : Second revised edition 500
The Social Work Ethics Casebook: Cases and Commentary (revised 2nd ed.) 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5207263
求助须知:如何正确求助?哪些是违规求助? 4385281
关于积分的说明 13656356
捐赠科研通 4243841
什么是DOI,文献DOI怎么找? 2328389
邀请新用户注册赠送积分活动 1326091
关于科研通互助平台的介绍 1278303